PB2361: PREDIGA, EDUCATIONAL AND DIAGNOSIS PROJECT IN ACID SPHINGOMYELINASE DEFICIENCY DISEASE (ASMD) AND GAUCHER DISEASE (GD): RESULTS TO THE OBJECTIVE ACHIEVED OF 200 PATIENTS ANALYZED.

PB2361: PREDIGA, EDUCATIONAL AND DIAGNOSIS PROJECT IN ACID SPHINGOMYELINASE DEFICIENCY DISEASE (ASMD) AND GAUCHER DISEASE (GD): RESULTS TO THE OBJECTIVE ACHIEVED OF 200 PATIENTS ANALYZED.

Bibliographic Details
Main Authors:	J. Villarrubia, E. Calderon, M. Morado, V. Quintero, I. Vitoria, M. A. Torralba
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000852268.99527.9a

Similar Items

Gaucher Disease or Acid Sphingomyelinase Deficiency? The Importance of Differential Diagnosis
by: Miriam Giacomarra, et al.
Published: (2024-03-01)

Survival of patients with chronic acid sphingomyelinase deficiency (ASMD) in the United States: A retrospective chart review study
by: Ruth Pulikottil-Jacob, et al.
Published: (2024-03-01)

S295: CLINICAL RELEVANCE OF SPLEEN VOLUME AND PLATELET COUNT WITH BLEEDING EVENTS IN PATIENTS WITH ACID SPHINGOMYELINASE DEFICIENCY (ASMD)
by: M. Fournier, et al.
Published: (2022-06-01)

Diagnostic odyssey for patients with acid sphingomyelinase deficiency (ASMD): Exploring the potential indicators of diagnosis using quantitative and qualitative data
by: Andrew Doerr, et al.
Published: (2024-03-01)

Women with Gaucher Disease
by: Maria del Mar Meijon-Ortigueira, et al.
Published: (2024-03-01)

Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency
by: Maja Di Rocco, et al.
Published: (2023-07-01)

PB2551: GAUCHER DISEASE CURRICULUM: INCORPORATING GAUCHER DISEASE IN THE FIELD OF HEMATOLOGY
by: Argiris Symeonidis, et al.
Published: (2023-08-01)

Olipudase alfa approved for pediatric and adult patients with acid sphingomyelinase deficiency (ASMD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
by: Monica Penon-Portmann, et al.
Published: (2023-01-01)

Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults
by: Robin H. Lachmann, et al.
Published: (2023-04-01)

Production performance analysis of sheep MSTN gene C2361T locus
by: Yuan Pan, et al.
Published: (2024-06-01)

PB2361: DIFFUSE LARGE B-CELL LYMPHOMA IN THE ELDERLY: RETROSPECTIVE ANALYSIS FROM A SINGLE CANCER CENTER IN ALGIERS
by: Talbi Faiza, et al.
Published: (2023-08-01)

Gaucher Disease and Gaucher Cells
by: Sevgi Gözdaşoğlu
Published: (2015-05-01)

Effect of macrophage-targeted glucocerebrosidase(alglucerase) on hypolipidaemia of type 1 Gaucher disease(GD)
by: Mistry, P, et al.
Published: (1997)

Sphingomyelinases and Liver Diseases
by: Naroa Insausti-Urkia, et al.
Published: (2020-10-01)

Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism
by: Makaila L. Furderer, et al.
Published: (2022-05-01)

Gaucher disease.
by: Butters, T
Published: (2007)

Gaucher Disease
by: Guilherme Henrique Hencklain Fonseca, et al.
Published: (2007-03-01)

Gaucher′s disease
by: Vijay Bohra, et al.
Published: (2011-01-01)

Autopsy pathology of infantile neurovisceral ASMD (Niemann-Pick Disease type A): Clinicopathologic correlations of a case report
by: Beth L. Thurberg
Published: (2020-09-01)

Signs and symptoms in Gaucher Disease: priority nursing diagnoses
by: Márcia Koja Breigeiron, et al.

Gaucher Disease for Hematologists
by: Gül Nihal Özdemir, et al.
Published: (2022-05-01)

Assessment of quality of life in Gaucher disease: A methodological approach
by: Vitória S. Zizemer, et al.
Published: (2021-01-01)

Gaucher's disease management protocol
by: E. A. Lukina, et al.
Published: (2022-11-01)

Lung Involvement in Gaucher Disease
by: Mahnaz Pejman Sani, et al.
Published: (2020-04-01)

Enzyme replacement in Gaucher disease.
by: Ernest Beutler
Published: (2004-11-01)

Prevalence and management of Gaucher disease
by: Burrow TA, et al.
Published: (2011-06-01)

Management algorithms for gaucher disease
by: Ayman Alhejazi, et al.
Published: (2020-01-01)

Hemorrhagic Aspects of Gaucher Disease
by: Hanna Rsenbaum
Published: (2014-10-01)

Splenic lipids in Gaucher's disease
by: N.G. Kennaway, et al.
Published: (1968-11-01)

Exodontia in patient with Gaucher's disease
by: Guacyra Machado Lisboa, et al.
Published: (2011-12-01)

The structure of cerebrosides in Gaucher's disease*
by: G.V. Marinetti, et al.
Published: (1960-04-01)

PB1939: CLINICAL AND GENETIC CHARACTERISTICS OF PATIENTS WITH GAUCHER DISEASE: A SINGLE CENTER EXPERIENCE
by: S. Elsayed, et al.
Published: (2022-06-01)

The Importance of a Multidisciplinary Approach in the Management of a Patient with Type I Gaucher Disease
by: Miguel-Ángel Torralba-Cabeza, et al.
Published: (2018-07-01)

New correlations between ocular parameters and disease severity in Spanish patients with Gaucher's disease Type I.
by: Olivia Esteban, et al.
Published: (2021-01-01)

New correlations between ocular parameters and disease severity in Spanish patients with Gaucher’s disease Type I
by: Olivia Esteban, et al.
Published: (2021-01-01)

Role of sphingomyelinase in infectious diseases caused by Bacillus cereus.
by: Masataka Oda, et al.
Published: (2012-01-01)

Animal Models for the Study of Gaucher Disease
by: Or Cabasso, et al.
Published: (2023-11-01)

Gaucher Disease in Internal Medicine and Dentistry
by: Michele Basilicata, et al.
Published: (2023-03-01)

Animal models for Gaucher disease research
by: Tamar Farfel-Becker, et al.
Published: (2011-11-01)

Dental profile of patients with Gaucher disease
by: Mann Jonathan, et al.
Published: (2003-07-01)